DK204684D0 - Humant vaeksthormon frit for andre proteiner forbundet med dets native miljoe,udtrykkelsesmedium,som kan frembringe produktion af prae-hgh i en prokaryotisk vaertscelle,prokaryotisk vaert transformeret dermed og fremgangsmaade til fremstilling af modent hgh - Google Patents

Humant vaeksthormon frit for andre proteiner forbundet med dets native miljoe,udtrykkelsesmedium,som kan frembringe produktion af prae-hgh i en prokaryotisk vaertscelle,prokaryotisk vaert transformeret dermed og fremgangsmaade til fremstilling af modent hgh

Info

Publication number
DK204684D0
DK204684D0 DK2046/84A DK204684A DK204684D0 DK 204684 D0 DK204684 D0 DK 204684D0 DK 2046/84 A DK2046/84 A DK 2046/84A DK 204684 A DK204684 A DK 204684A DK 204684 D0 DK204684 D0 DK 204684D0
Authority
DK
Denmark
Prior art keywords
thermalged
prokaryotically
prae
procaryotic
hgh
Prior art date
Application number
DK2046/84A
Other languages
English (en)
Other versions
DK204684A (da
Inventor
Gregory Lawrence Gray
Herbert Louis Heyneker
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK204684D0 publication Critical patent/DK204684D0/da
Publication of DK204684A publication Critical patent/DK204684A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK204684A 1983-04-25 1984-04-24 Humant vaeksthormon frit for andre proteiner forbundet med dets native miljoe, udtrykkelsesmedium, som kan frembringe produktion af prae-hgh i en prokaryotisk vaertscelle, prokaryotisk vaert transformeret dermed og fremgangsmaade til fremstilling af modent hgh DK204684A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/488,232 US4755465A (en) 1983-04-25 1983-04-25 Secretion of correctly processed human growth hormone in E. coli and Pseudomonas

Publications (2)

Publication Number Publication Date
DK204684D0 true DK204684D0 (da) 1984-04-24
DK204684A DK204684A (da) 1984-10-26

Family

ID=23938879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK204684A DK204684A (da) 1983-04-25 1984-04-24 Humant vaeksthormon frit for andre proteiner forbundet med dets native miljoe, udtrykkelsesmedium, som kan frembringe produktion af prae-hgh i en prokaryotisk vaertscelle, prokaryotisk vaert transformeret dermed og fremgangsmaade til fremstilling af modent hgh

Country Status (9)

Country Link
US (1) US4755465A (da)
EP (1) EP0127305A1 (da)
JP (2) JPS6045595A (da)
CA (1) CA1267099A (da)
DK (1) DK204684A (da)
ES (1) ES531896A0 (da)
IL (1) IL71622A (da)
NZ (1) NZ207924A (da)
ZA (1) ZA843062B (da)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
US5618697A (en) * 1982-12-10 1997-04-08 Novo Nordisk A/S Process for preparing a desired protein
US4859600A (en) * 1983-04-25 1989-08-22 Genentech, Inc. Recombinant procaryotic cell containing correctly processed human growth hormone
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
DE3588249T2 (de) * 1984-08-16 2004-05-06 Savient Pharmaceuticals, Inc. Methode zur Herstellung von menschlichen Wachstumshormonen
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US4861868A (en) 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US5013662A (en) * 1985-09-20 1991-05-07 Cetus Corporation Bacterial methionine n-terminal peptidase
US4870017A (en) * 1985-09-20 1989-09-26 Cetus Corporation Bacterial methionine N-terminal peptidase
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
FR2597114B1 (fr) * 1986-04-10 1994-02-25 Sanofi Procede microbiologique pour l'obtention d'une proteine par culture d'une souche bacterienne mutante
FR2599753B1 (fr) * 1986-06-05 1989-12-08 Sanofi Sa Sequence d'adn composite et son application pour la production de l'hormone de croissance
IT1228925B (it) * 1987-08-07 1991-07-10 Eniricerche Spa Procedimento per la preparazione dell'ormone della crescita umano
US5744139A (en) * 1991-06-28 1998-04-28 University Of Tennessee Research Corporation Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
US5317012A (en) * 1991-10-04 1994-05-31 The University Of Tennessee Research Corporation Human growth hormone induced improvement in depressed T4/T8 ratio
CA2098599A1 (en) * 1991-10-16 1993-04-17 William F. Swain Particle-mediated transformation of animal somatic cells
JPH07118577B2 (ja) * 1992-12-02 1995-12-18 株式会社リコー 電子装置用基板の検査方法
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
MX9605082A (es) 1996-10-24 1998-04-30 Univ Autonoma De Nuevo Leon Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
BRPI0210579B8 (pt) * 2001-06-26 2021-05-25 Amgen Fremont Inc anticorpo e composição farmacêutica
PL205888B1 (pl) * 2001-07-06 2010-06-30 Lg Life Sciences Ltd Aminopeptydaza, gen kodujący aminopeptydazę, wektor ekspresyjny, transformant Escherichia coli i sposób wytwarzania białka typu naturalnego
MXPA04007886A (es) 2002-02-13 2004-10-15 Dow Global Technologies Inc Sobre-expresion de genes de extremozimo en pseudomonadas y bacterias estrechamente relacionadas.
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
KR20060015595A (ko) * 2003-05-09 2006-02-17 파멕사 에이/에스 해독된 ｔｎｆ 및 그의 제조 방법
JP2007501011A (ja) * 2003-08-01 2007-01-25 ジェネンテック・インコーポレーテッド 制限多様性配列を有する結合型ポリペプチド
AU2004293810B2 (en) * 2003-11-19 2010-07-01 Pelican Technology Holdings, Inc. Improved protein expression systems
WO2005089093A2 (en) 2003-11-21 2005-09-29 Dow Global Technologies Inc. Improved expression systems with sec-system secretion
AU2004313458B2 (en) * 2003-12-01 2010-07-22 Pfenex Inc. Recombinant icosahedral virus like particle production in pseudomonads
BRPI0506917A (pt) 2004-01-16 2007-06-05 Dow Global Technologies Inc expressão de proteìnas de mamìferos em pseudomonas fluorescens
US8778880B2 (en) 2004-02-02 2014-07-15 Ambrx, Inc. Human growth hormone modified at position 35
NZ551335A (en) * 2004-06-18 2010-03-26 Ambrx Inc Antibodies and fragments thereof comprising an non naturally encoded amino acid coupled to a linker
AU2004320986A1 (en) * 2004-06-23 2006-01-05 Usv Limited Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
BRPI0512396A (pt) * 2004-07-21 2008-03-11 Ambrx Inc polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2006073846A2 (en) 2004-12-22 2006-07-13 Ambrx, Inc. Methods for expression and purification of recombinant human growth hormone
AU2005319518B2 (en) * 2004-12-22 2010-09-09 Ambrx, Inc. Compositions of aminoacyl-tRNA synthetase and uses thereof
NZ584597A (en) 2004-12-22 2011-09-30 Ambrx Inc Modified human growth hormone
CN103520735B (zh) 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
MX2007015058A (es) * 2005-06-03 2008-01-28 Ambrx Inc Moleculas de interferon humano mejoradas y sus usos.
DK1937824T3 (da) 2005-08-18 2013-04-02 Ambrx Inc Sammensætninger af tRNA og anvendelser deraf
US8679490B2 (en) 2005-11-07 2014-03-25 Genentech, Inc. Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
WO2007056448A2 (en) * 2005-11-08 2007-05-18 Ambrx, Inc. Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
ES2547554T3 (es) * 2005-11-16 2015-10-07 Ambrx, Inc. Métodos y composiciones que comprenden aminoácidos no naturales
EP1957540B1 (en) * 2005-12-02 2012-06-13 Genentech, Inc. Binding polypeptides and uses thereof
EP1973951A2 (en) * 2005-12-02 2008-10-01 Genentech, Inc. Binding polypeptides with restricted diversity sequences
ES2529065T3 (es) * 2005-12-14 2015-02-16 Ambrx, Inc. Composiciones que contienen, procedimientos que implican y usos de aminoácidos no naturales y polipéptidos
US8420792B2 (en) * 2006-09-08 2013-04-16 Ambrx, Inc. Suppressor tRNA transcription in vertebrate cells
PT2061878E (pt) * 2006-09-08 2014-04-22 Ambrx Inc Supressor híbrido arnt para células de vertebrados
EP2069396B1 (en) * 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
BRPI0807834A2 (pt) 2007-01-31 2014-07-22 Dow Global Technologies Inc " sequências-líder bacterianas para expressão aumentada ".
AU2008232937B2 (en) 2007-03-30 2012-09-27 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
MX2009011523A (es) 2007-04-27 2009-11-09 Dow Global Technologies Inc Metodo para clasificar rapidamente huespedes microbianos para identificar ciertas cepas con rendimiento y/o calidad mejorados en la expresion de proteinas heterologas.
EP2076533B1 (en) * 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5547083B2 (ja) * 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
US20110020830A1 (en) * 2008-03-31 2011-01-27 Schneider Jane C Design for rapidly cloning one or more polypeptide chains into an expression system
NZ600382A (en) * 2008-07-23 2013-11-29 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
MX348657B (es) 2008-09-26 2017-06-21 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
AU2009296397B2 (en) * 2008-09-26 2012-11-08 Ambrx Inc. Modified animal erythropoietin polypeptides and their uses
ES2640947T3 (es) 2009-05-11 2017-11-07 Pfenex, Inc. Producción de proteínas recombinantes utilizando métodos de selección no antibióticos y la incorporación de aminoácidos no naturales en las mismas
MX2012010148A (es) 2010-03-04 2013-01-22 Pfenex Inc Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion.
AU2011238711B2 (en) 2010-03-30 2015-06-18 Pelican Technology Holdings, Inc. High level expression of recombinant toxin proteins
AU2011235210B2 (en) 2010-04-01 2015-07-16 Pfenex Inc. Methods for G-CSF production in a Pseudomonas host cell
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AU2011291943B2 (en) 2010-08-17 2015-01-22 Ambrx, Inc. Modified relaxin polypeptides and their uses
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
JP6702962B2 (ja) 2014-10-24 2020-06-03 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 改変ｆｇｆ−２１ポリペプチドおよびその使用
BR112017010718A2 (pt) 2014-11-20 2017-12-26 Biological E Ltd polinucleotídeo otimizado por códon para expressão de alto nível de crm197
WO2016089782A1 (en) 2014-12-01 2016-06-09 Pfenex Inc. Fusion partners for peptide production
MY193457A (en) 2017-02-08 2022-10-14 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
EP3700921A4 (en) 2017-10-27 2021-12-15 Pfenex Inc. PROCESS FOR THE PRODUCTION OF RECOMBINANT ERWINIA ASPARAGINASE
KR20200073280A (ko) 2017-10-27 2020-06-23 피페넥스 인크. 주변세포질 단백질 발현을 위한 박테리아 리더 서열
US20220227805A1 (en) 2020-12-23 2022-07-21 Jazz Pharmaceuticals Ireland Ltd. Methods of purifying charge-shielded fusion proteins
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
GR68404B (da) * 1979-06-01 1981-12-29 Univ California
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
GR76959B (da) * 1981-01-02 1984-09-04 Univ New York State Res Found
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
GB2121054B (en) * 1982-05-25 1986-02-26 Lilly Co Eli Cloning vectors for expression of exogenous protein
JPS59135892A (ja) * 1983-01-25 1984-08-04 Kunio Yamane シグナルアミノ酸配列をコードするｄｎａ

Also Published As

Publication number Publication date
EP0127305A1 (en) 1984-12-05
JPH05252936A (ja) 1993-10-05
ES8602136A1 (es) 1985-12-01
US4755465A (en) 1988-07-05
NZ207924A (en) 1988-03-30
IL71622A0 (en) 1984-07-31
JPS6045595A (ja) 1985-03-12
DK204684A (da) 1984-10-26
IL71622A (en) 1990-03-19
CA1267099A (en) 1990-03-27
AU2721984A (en) 1984-11-01
ES531896A0 (es) 1985-12-01
ZA843062B (en) 1984-11-28
AU586609B2 (en) 1989-07-20

Similar Documents

Publication Publication Date Title
DK204684A (da) Humant vaeksthormon frit for andre proteiner forbundet med dets native miljoe, udtrykkelsesmedium, som kan frembringe produktion af prae-hgh i en prokaryotisk vaertscelle, prokaryotisk vaert transformeret dermed og fremgangsmaade til fremstilling af modent hgh
DK0574402T3 (da) Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
ATE100858T1 (de) Pflanzengewebe-transformation.
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
DK198883A (da) Fremgangsmaade til fremstilling af menneskevaevs-plasminogen-aktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og mikroorganisme eller cellekultur transformeret med udtrykkelsesvektoren
ES8800987A1 (es) Metodo de produccion del factor viii:c humano
IT7923496A0 (it) Metodo per la produzione di corpi di vetro, in particolare filamenti ottici.
IL83192A (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
ES8307500A1 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
IT8220140A0 (it) Procedimento per la produzione di sostanze prodotte da cellule, particolarmente di anticorpi esimili.
DE69130981D1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
DK268882A (da) Fremgangsmaade til fremstilling af et polypeptid, dna-sekvens, som koder for polypeptidet, replicerbart mikrobielt udtrykkelsesmedium, som i en transformant-mikroorganisme er i stand til at udtrykke polypeptidet og kultur af en mikroorganisme transformeret dermed
NO863535L (no) Linseholder, saerlig holder for brilleglass som skal rengjoeres og deretter paafoeres belegg.
DK358787D0 (da) Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren
DK133780A (da) Fremgangsmaade til fremstilling af interferon
DK0547064T3 (da) Proteaseresistent PDGF og anvendelsesfremgangsmåde
IT8448540A0 (it) Proteine umane, antisieri per esse, procedimento per prepararli e corredi di prova che li contengono
MY103362A (en) Production of proteins in active forms
DK262784D0 (da) Mikrobiologisk fremstillet d-2-hydroxy-4-methylpentansyredehydrogenase, fremgangsmaade til dets udvinding og dets anvendelse
RO91666A (ro) Procedeu pentru prepararea unor derivati de acid fenoxiprostatrienoic
DE300666T1 (de) Gefaess fuer zellkultur im batch-verfahren.
DK428184D0 (da) 2-oxocarbonsyrereduktase, fremgangsmaade til fremstilling heraf samt anvendelse heraf til reduktion af 2-oxocarbonsyrer og disses estere
IT8119533A0 (it) Metodo per la produzione di isomerasi del glucosio immobilizzata.
DK285587D0 (da) Ekspressionsvektor med evne til inducibar ekspression af et fremmed strukturgen, der baeres af ekspressionsvektoren, i vaertsceller og fremgangsmaade tilfremstilling af oenskede genprodukter
DK282387D0 (da) Sammensat dna-sekvens og dennes anvendelse til fremstilling af vaeksthormon

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment